A panel discussion about the revolutionary gene editing technique
Last year’s Nobel Prize in chemistry was awarded to professor Jennifer Doudna and professor Emanuelle Charpentier for the development of the CRISPR-Cas9 technique. In the past decade, this gene editing technology has been developed at a rapid pace. CRISPR-Cas9 makes it possible to precisely adjust tiny pieces of DNA and is being developed with the goal to cure genetic diseases. This technology will therefore most likely be used in medicine in the future. Due to its broad applicability in gene editing, it is highly probable that it will also be used for other purposes which brings up a lot of ethical questions.